First Time Loading...

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 32.08 CNY 0.82% Market Closed
Updated: May 1, 2024

Wall Street
Price Targets

Price Targets Summary
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Wall Street analysts forecast Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is 32.31 CNY with a low forecast of 23.23 CNY and a high forecast of 44.1 CNY.

Lowest
Price Target
23.23 CNY
28% Downside
Average
Price Target
32.31 CNY
1% Upside
Highest
Price Target
44.1 CNY
37% Upside
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors:
Price Targets
063160
CKD Bio Corp
11% Upside
1760
Panion & BF Biotech Inc
14% Upside
002001
Zhejiang Nhu Co Ltd
6% Upside
214370
Caregen Co Ltd
132% Upside
600535
Tasly Pharmaceutical Group Co Ltd
2% Downside
PFIZER
Pfizer Ltd
9% Upside
PFE
Pfizer Inc
19% Upside

Revenue
Forecast

Revenue Estimate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 4%.

19%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 4%.

19%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's net income is 15%. The projected CAGR for the next 3 years is -11%.

15%
Past Growth
-11%
Estimated Growth
Estimates Accuracy
10%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's stock price target?
Price Target
32.31 CNY

According to Wall Street analysts, the average 1-year price target for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is 32.31 CNY with a low forecast of 23.23 CNY and a high forecast of 44.1 CNY.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 4%.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Operating Income forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 4%.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Net Income forecast?
Projected CAGR
-11%

For the last 8 years the compound annual growth rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's net income is 15%. The projected CAGR for the next 3 years is -11%.